Midway through trading Monday, the Dow traded up 1.94% to 35,251.31 while the NASDAQ rose 0.55% to 15,168.35. The S&P also rose, gaining 1.20% to 4,592.83.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 49,969,850 cases with around 808,760 deaths. India confirmed a total of at least 34,641,560 cases and 473,530 deaths, while Brazil reported over 22,143,090 COVID-19 cases with 615,670 deaths. In total, there were at least 266,264,960 cases of COVID-19 worldwide with more than 5,273,750 deaths.
Leading and Lagging Sectors
Utilities shares climbed 2.4% on Monday. Meanwhile, top gainers in the sector included PG&E Corporation PCG, up 5% and Unitil Corporation UTL up 6%.
In trading on Monday, health care shares rose by just 0.4%.
Science Applications International Corporation SAIC reported better-than-expected earnings for its third quarter and raised its FY22 forecast.
Science Applications reported a quarterly profit of $1.85 per share, beating analysts’ estimates of $1.50 per share. The company’s quarterly sales came in at $1.90 billion, versus expectations of $1.88 billion.
Science Applications raised its FY22 EPS guidance from $6.50-$6.70 to $6.75-$6.95. The company also boosted sales guidance from $7.3 billion-$7.4 billion to $7.35 billion -$7.40 billion.
Equities Trading UP
Del Taco Restaurants, Inc. TACO shares shot up 65% to $12.42. Jack In The Box Inc JACK agreed to acquire Del Taco Restaurants for $12.51 per share in cash in a deal valued at about $575 million.
Shares of Insignia Systems, Inc. ISIG got a boost, shooting 41% to $7.05 after the company reported review of strategic alternatives.
Adicet Bio, Inc. ACET shares were also up, gaining 41% to $13.78 after the company announced interim data from its dose escalation Phase 1 study evaluating the safety and tolerability of ADI-001.
Equities Trading DOWN
Bolt Biotherapeutics, Inc. BOLT shares tumbled 49% to $5.35. Bolt Biotherapeutics announced the presentation of interim clinical data from its Phase 1/2 study of BDC-1001.
Shares of Aeglea BioTherapeutics, Inc. AGLE were down 34% to $3.98 after the company announced data from the Phase 3 study of pegzilarginase in Arginase 1 Deficiency (ARG1-D) patients aged two years and older. ARG1-D is a rare disease characterized by high levels of the amino acid arginine. The disease manifestations include spasticity, developmental delay, intellectual disability, and seizures.
Alset EHome International Inc. AEI was down, falling 43% to $0.6125 after the company priced its $30 million underwritten public offering.
In commodity news, oil traded up 3.1% to $68.33, while gold traded down 0.2% to $1,781.30.
Silver traded down 0.6% Monday to $22.34 while copper rose 1% to $4.3115.
European shares were higher today. The eurozone’s STOXX 600 gained 1.29%, the Spanish Ibex Index rose 2.29% and the German DAX 30 gained 0.84%. Meanwhile, the London’s FTSE 100 climbed 0.8%, French CAC 40 jumped 0.62% and Italy’s FTSE MIB surged 1.88%.
The IHS Markit Eurozone construction PMI climbed to 53.3 in November from 51.2 in October, while German construction PMI rose to 47.9 in November from 47.7 a month ago. New orders for German manufactured goods dropped 6.9% in October. The IHS Markit Italy construction PMI surged to 65.5 in November from 58.6 in the previous month, while French construction PMI rose to 51.6 in November from 50.3.
The Investor Movement Index for November will be released at 12:30 p.m. ET.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.